Literature DB >> 29712818

Hematopoietic stem cell mobilization with plerixafor in sickle cell disease.

Matthew M Hsieh1, John F Tisdale2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29712818      PMCID： PMC5927977          DOI： 10.3324/haematol.2018.190876

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients.

Authors:  Naoya Uchida; Atsushi Fujita; Matthew M Hsieh; Aylin C Bonifacino; Allen E Krouse; Mark E Metzger; Robert E Donahue; John F Tisdale
Journal:  Hum Gene Ther Clin Dev       Date:  2017-04-17       Impact factor: 5.032

2.  Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.

Authors:  Peiman Hematti; Sascha Tuchman; Andre Larochelle; Mark E Metzger; Robert E Donahue; John F Tisdale
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

3.  Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixafor.

Authors:  Naoya Uchida; Aylin Bonifacino; Allen E Krouse; Mark E Metzger; Gyorgy Csako; Agnes Lee-Stroka; Ross M Fasano; Susan F Leitman; Joseph J Mattapallil; Matthew M Hsieh; John F Tisdale; Robert E Donahue
Journal:  Exp Hematol       Date:  2011-04-15       Impact factor: 3.084

4.  Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?

Authors:  Courtney D Fitzhugh; Matthew M Hsieh; Charles D Bolan; Carla Saenz; John F Tisdale
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

5.  Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trial.

Authors:  Jeremy Pantin; Enkhtsetseg Purev; Xin Tian; Lisa Cook; Theresa Donohue-Jerussi; Elena Cho; Robert Reger; Matthew Hsieh; Hanh Khuu; Gary Calandra; Nancy L Geller; Richard W Childs
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

6.  Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion.

Authors:  Chantal Lagresle-Peyrou; François Lefrère; Elisa Magrin; Jean-Antoine Ribeil; Oriana Romano; Leslie Weber; Alessandra Magnani; Hanem Sadek; Clémence Plantier; Aurélie Gabrion; Brigitte Ternaux; Tristan Félix; Chloé Couzin; Aurélie Stanislas; Jean-Marc Tréluyer; Lionel Lamhaut; Laure Joseph; Marianne Delville; Annarita Miccio; Isabelle André-Schmutz; Marina Cavazzana
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 9.941

7.  Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.

Authors:  Farid Boulad; Tsiporah Shore; Koen van Besien; Caterina Minniti; Mihaela Barbu-Stevanovic; Sylvie Wiener Fedus; Fabiana Perna; June Greenberg; Danielle Guarneri; Vijay Nandi; Audrey Mauguen; Karina Yazdanbakhsh; Michel Sadelain; Patricia A Shi
Journal:  Haematologica       Date:  2018-02-01       Impact factor: 9.941
  7 in total
  6 in total

1.  Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients.

Authors:  Erica B Esrick; John P Manis; Heather Daley; Cristina Baricordi; Hélène Trébéden-Negre; Francis J Pierciey; Myriam Armant; Sarah Nikiforow; Matthew M Heeney; Wendy B London; Luca Biasco; Mohammed Asmal; David A Williams; Alessandra Biffi
Journal:  Blood Adv       Date:  2018-10-09

Review 2.  Therapeutic strategies for sickle cell disease: towards a multi-agent approach.

Authors:  Marilyn J Telen; Punam Malik; Gregory M Vercellotti
Journal:  Nat Rev Drug Discov       Date:  2019-02       Impact factor: 84.694

3.  AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse.

Authors:  Clare Samuelson; Stefan Radtke; Margaret Cui; Anai Perez; Hans-Peter Kiem; Olivier Humbert
Journal:  Exp Hematol       Date:  2020-12-01       Impact factor: 3.084

4.  Bibliometric analysis of global sickle cell disease research from 1997 to 2017.

Authors:  Henshaw Uchechi Okoroiwu; Francisco López-Muñoz; F Javier Povedano-Montero
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-28

Review 5.  Research in Sickle Cell Disease: From Bedside to Bench to Bedside.

Authors:  Gabriel Salinas Cisneros; Swee Lay Thein
Journal:  Hemasphere       Date:  2021-06-01

Review 6.  Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization.

Authors:  Jian Chen; Hillard M Lazarus; Parastoo B Dahi; Scott Avecilla; Sergio A Giralt
Journal:  Blood Rev       Date:  2020-10-31       Impact factor: 10.626
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.